98 related articles for article (PubMed ID: 8386005)
1. An ACTH 4-9 analog (Org 2766) and cognitive performance: high-dose efficacy and safety in dementia of the Alzheimer's type.
Miller TP; Fong K; Tinklenberg JR
Biol Psychiatry; 1993 Feb; 33(4):307-9. PubMed ID: 8386005
[No Abstract] [Full Text] [Related]
2. First clinical impressions with an ACTH analog (HOE 427) in the treatment of Alzheimer's disease.
Siegfried KR
Ann N Y Acad Sci; 1991; 640():280-3. PubMed ID: 1663715
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog.
Soininen H; Koskinen T; Helkala EL; Pigache R; Riekkinen PJ
Neurology; 1985 Sep; 35(9):1348-51. PubMed ID: 2991817
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease.
Heuser I; Heuser-Link M; Gotthardt U; Grasser A; Holsboer F
J Clin Psychopharmacol; 1993 Jun; 13(3):171-4. PubMed ID: 8394847
[TBL] [Abstract][Full Text] [Related]
5. Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease?
Partanen JV; Soininen H; Riekkinen PJ
Electroencephalogr Clin Neurophysiol; 1986 Jun; 63(6):547-51. PubMed ID: 2422004
[TBL] [Abstract][Full Text] [Related]
6. The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease.
Jolkkonen JT; Soininen HS; Riekkinen PJ
Life Sci; 1985 Aug; 37(7):585-90. PubMed ID: 2991689
[TBL] [Abstract][Full Text] [Related]
7. An analog of MSH/ACTH 4-9 enhances interpersonal and environmental awareness in mentally retarded adults.
Sandman CA; Walker BB; Lawton CA
Peptides; 1980; 1(1):109-14. PubMed ID: 7243605
[TBL] [Abstract][Full Text] [Related]
8. [Recent drug therapy of senile dementia].
Ohtomo E
No To Shinkei; 1987 Jan; 39(1):49-58. PubMed ID: 3030382
[No Abstract] [Full Text] [Related]
9. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
[TBL] [Abstract][Full Text] [Related]
10. Early visual information processing in depressive patients treated with ORG 2766 (an ACTH 4-9 analogue).
d'Elia G; Frederiksen SO; Bengtsson BO
Neuropsychobiology; 1985; 13(1-2):63-8. PubMed ID: 2993946
[TBL] [Abstract][Full Text] [Related]
11. Some effects of an ACTH 4-9 analog (Org 2766) on human performance.
Gaillard AW; Varey CA
Physiol Behav; 1979 Jul; 23(1):79-84. PubMed ID: 229501
[TBL] [Abstract][Full Text] [Related]
12. The adrenocorticotrophic hormone (4-9) analog ORG 2766 benefits autistic children: report on a second controlled clinical trial.
Buitelaar JK; van Engeland H; de Kogel K; de Vries H; van Hooff J; van Ree J
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1149-56. PubMed ID: 1331023
[TBL] [Abstract][Full Text] [Related]
13. Preliminary communication. A double-blind placebo-controlled trial of L-tryptophan to assess the degree of cognitive and behavioural improvement in patients with Alzheimer-type dementia and to compare differential response in clinical sub-groups.
Bentham PW
Int Clin Psychopharmacol; 1990 Oct; 5(4):261-72. PubMed ID: 2081897
[No Abstract] [Full Text] [Related]
14. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
Small G; Erkinjuntti T; Kurz A; Lilienfeld S
CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
[TBL] [Abstract][Full Text] [Related]
15. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.
Sahakian BJ; Owen AM; Morant NJ; Eagger SA; Boddington S; Crayton L; Crockford HA; Crooks M; Hill K; Levy R
Psychopharmacology (Berl); 1993; 110(4):395-401. PubMed ID: 7870908
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls.
Sunderland T; Tariot PN; Mueller EA; Murphy DL; Weingartner H; Cohen RM
Psychopharmacol Bull; 1985; 21(3):676-9. PubMed ID: 3898182
[No Abstract] [Full Text] [Related]
17. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study.
den Boer JA; Westenberg HG; Mastenbroek B; van Ree JM
Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650
[No Abstract] [Full Text] [Related]
18. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN
Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin replacement therapy for Alzheimer dementia.
Mouradian MM; Blin J; Giuffra M; Heuser IJ; Baronti F; Ownby J; Chase TN
Ann Neurol; 1991 Oct; 30(4):610-3. PubMed ID: 1789687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
